Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-25 @ 2:32 AM
NCT ID:
NCT03358134
Eligibility Criteria:
Inclusion Criteria:
* Male or non-pregnant/non-lactating females age 18-70
* Diagnosis of SpA according to ESSG criteria and/or ASAS criteria
* Active disease defined by ≥1 swollen and ≥ 1 tender joint, and at least 1 swollen knee or ankle joint at baseline
Exclusion Criteria:
* Evidence for infectious or malignant process (on chest X ray/MRI etc)
* Patients taking opioid analgetics
* Previous IL-17 therapy exposure
* Previous use of cell-depleting therapies, biological immunomodulators (except for TNF blockade , as 25% may have been previously treated with 1 TNF blocking agent)
* Significant medical problems or diseases
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT03358134
Study Brief:
Protocol Section:
NCT03358134